在住院的COVID-19患者中利用血液成分:来自专门的COVID-19中心的经验
在PubMed上查看摘要
概括
此摘要是机器生成的。在COVID-19患者中,血液成分的利用率较低,主要是那些患有并发症或需要重症护理的人. 红细胞是最常被输血的组成部分,而凝血病并不是需要输血的原因.
科学领域
- 血液学
- 输血医学
- 传染性疾病
背景情况
- COVID-19 大流行影响了输血服务.
- 关于COVID-19患者的输血需求的知识有限.
- 了解输血需求对于血液库存管理至关重要.
研究的目的
- 分析住院COVID-19患者的血液成分利用情况.
- 评估接受输血的COVID-19患者的结果.
- 在流行病期间为血液库存管理策略提供信息.
主要方法
- 对接受输血的COVID-19患者的回顾性分析.
- 包括患者的人口统计,临床状况,并发症和实验室参数.
- 从血液银行和患者记录中收集输血细节.
主要成果
- 12.9% 的住院COVID-19患者 (395/3052) 接受了输血.
- 红细胞是最常见的输血成分 (11. 4%),其次是血小板和新鲜冷血.
- 患有并发症和需要重症监护或通风的患者需要更多的红细胞.
结论
- 在COVID-19患者中,血液成分的利用率通常很低.
- 之前存在的并发症和急性护理需求是输血的主要驱动因素.
- 红细胞是输血的主要成分;凝血病不需要输血.
相关概念视频
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

